Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,858 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia.
Ashizawa M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y. Ashizawa M, et al. Among authors: kimura s. Int J Hematol. 2014 Mar;99(3):311-7. doi: 10.1007/s12185-014-1501-6. Epub 2014 Feb 1. Int J Hematol. 2014. PMID: 24488782
Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation.
Miyamura F, Kako S, Yamagami H, Sato K, Sato M, Terasako K, Kimura SI, Nakasone H, Aoki S, Okuda S, Yamazaki R, Oshima K, Yoshinaga K, Higuchi T, Nishida J, Demitsu T, Kakehashi A, Kanda Y. Miyamura F, et al. Among authors: kimura si. Int J Hematol. 2009 Oct;90(3):397-401. doi: 10.1007/s12185-009-0406-2. Epub 2009 Aug 25. Int J Hematol. 2009. PMID: 19705056
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
Kimura S, Oshima K, Okuda S, Sato K, Sato M, Terasako K, Nakasone H, Kako S, Yamazaki R, Tanaka Y, Tanihara A, Higuchi T, Nishida J, Kanda Y. Kimura S, et al. Bone Marrow Transplant. 2010 Jun;45(6):1088-94. doi: 10.1038/bmt.2009.316. Epub 2009 Nov 9. Bone Marrow Transplant. 2010. PMID: 19898510 Clinical Trial.
Retrospective evaluation of the area over the neutrophil curve index to predict early infection in hematopoietic stem cell transplantation recipients.
Kimura S, Oshima K, Sato K, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Yamazaki R, Tanaka Y, Tanihara A, Nishida J, Kanda Y. Kimura S, et al. Biol Blood Marrow Transplant. 2010 Oct;16(10):1355-61. doi: 10.1016/j.bbmt.2010.04.012. Epub 2010 May 10. Biol Blood Marrow Transplant. 2010. PMID: 20457267 Free article.
Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Tanaka Y, Nakasone H, Yamazaki R, Sato K, Sato M, Terasako K, Kimura S, Okuda S, Kako S, Oshima K, Tanihara A, Nishida J, Yoshikawa T, Nakatsura T, Sugiyama H, Kanda Y. Tanaka Y, et al. Among authors: kimura s. Cancer Res. 2010 Aug 1;70(15):6181-92. doi: 10.1158/0008-5472.CAN-10-0678. Epub 2010 Jul 20. Cancer Res. 2010. PMID: 20647322
Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation.
Ishida Y, Terasako K, Oshima K, Sakamoto K, Ashizawa M, Sato M, Kikuchi M, Kimura S, Nakasone H, Okuda S, Kako S, Yamazaki R, Nishida J, Kanda Y. Ishida Y, et al. Among authors: kimura s. Int J Hematol. 2010 Oct;92(3):542-6. doi: 10.1007/s12185-010-0678-6. Epub 2010 Sep 8. Int J Hematol. 2010. PMID: 20824399
5,858 results